Evidence map›Paper›PMID 19534024›Full record

ReviewAdvances in enzyme regulation2009

A novel gene expression pathway regulated by nuclear phosphoinositides.

David L Mellman, Richard A Anderson

Abstract readReview
In one paragraph

Review in Advances in enzyme regulation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Phosphatidylinositol 4,5-bisphosphate: targeted production and signaling.BioEssays : news and reviews in molecular, cellular and developmental biology · 2013
    Review
  8. Article
  9. Article
  10. Article
  11. Specificity factors in cytoplasmic polyadenylation.Wiley interdisciplinary reviews. RNA
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David L MellmanDepartment of Pharmacology, Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison Medical Sciences Center, 1300 University Ave., Madison, WI 53706, USA.
Richard A Anderson

Funding

PHOSPHOINOSITIDE SIGNALING TO AND WITHIN THE NUCLEUSR01GM051968 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 1995 to 2012
$3.2M
PI Signaling Role in Epithelial/Mesenchymal TransitionR01CA104708 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 2004 to 2014
$2.9M
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene ExpressionR01GM114386 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 2016 to 2019
$1.5M
NCI NIH HHS R01 CA104708NIGMS NIH HHS R01 GM051968NIGMS NIH HHS R01 GM114386
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression RegulationCasein Kinase IalphaCell NucleusHumansIsoenzymesNuclear ProteinsNucleotidyltransferasesPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphotransferases (Alcohol Group Acceptor)Polynucleotide AdenylyltransferaseSignal TransductionCasein Kinase IalphaIsoenzymesNuclear ProteinsNucleotidyltransferasesPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphotransferases (Alcohol Group Acceptor)Polynucleotide AdenylyltransferaseTUT1 protein, human

Identifiers

PMID19534024
PMCPMC3302184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.